Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, June 19, 2014

GlycoMimetics Initiates First Clinical Trial of GMI-1271 as Potential ...

GlycoMimetics, Inc. announced today that the first healthy volunteer has been dosed in a Phase 1 clinical study designed to evaluate the safety, tolerability and pharmacokinetics of GMI-1271 , a novel and proprietary E-selectin antagonist in the company's pipeline.

http://ift.tt/1nkkhsA
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts